TTM
−$52.79M
YoY change
-19.0%
5Y CAGR
—
Peak year (2019)
−$6.55M
Cumulative net income
−$302.53M
Net Income history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: −$59.85M
Net Income growth chart for Climb Bio (CLYM) from 2019 to 2025
Latest: -19.0%
Net Income history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | −$59.85M | -19.0% | +$14.05M | ||
| 2024 | −$73.90M | +110.4% | −$38.78M | ||
| 2023 | −$35.12M | -22.4% | +$10.13M | ||
| 2022 | −$45.24M | -4.7% | +$2.24M | ||
| 2021 | −$47.48M | +129.7% | −$26.81M | ||
| 2020 | −$20.67M | +215.7% | −$14.12M | ||
| 2019 | −$6.55M | — | — |
- 2025−$59.85M-19.0%
- 2024−$73.90M+110.4%
- 2023−$35.12M-22.4%
- 2022−$45.24M-4.7%
- 2021−$47.48M+129.7%
- 2020−$20.67M+215.7%
- 2019−$6.55M—
Net Income values are taken from Climb Bio's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's current net income (TTM) is −$52.79M. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Climb Bio (CLYM) reported net income of −$59.85M – declined 19.0% year-over-year.
−$6.55M stands as the all-time-high annual net income, posted in 2019, against a low of −$73.90M during 2024.
Climb Bio Net Income by Year
Climb Bio Net Income 2025: −$59.85M
2025's net income for Climb Bio came in at −$59.85M, declined 19.0% below 2024.
Climb Bio Net Income 2024: −$73.90M
Climb Bio posted net income of −$73.90M in 2024, surged 110.4% from 2023. This figure represents the lowest annual value in the available history.
Climb Bio Net Income 2023: −$35.12M
In 2023, Climb Bio reported net income of −$35.12M, declined 22.4% below 2022.
Climb Bio Net Income 2022: −$45.24M
Climb Bio net income in 2022 was −$45.24M, edged down 4.7% below 2021.
Climb Bio Net Income 2021: −$47.48M
Climb Bio net income in 2021 was −$47.48M.
See more financial history for Climb Bio (CLYM).
Sector peers by Net Income
Healthcare peers of Climb Bio (CLYM), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation